The US Patent and Trademark Office (USPTO) has granted a new patent No. 8,221,117 B2 to Biolase's laser endodontic therapy system. The new patent relates to the ability of the radially fire or side firing endodontic probe to combine ...
Tags: laser endodontic therapy system, Biolase, US Patent and Trademark Office
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Echo Therapeutics' claimed application for its Prelude SkinPrep system and Symphony tCGM system. The claimed Patent Application No. 10/792,862 entitled ...
Tags: USPTO, NOA, application, notice of allowance, Prelude SkinPrep system
The US Patent and Trademark Office (USPTO) has granted patent No. 8,167,837 to Unilife's ready-to-fill (prefilled) syringe. The barrel of prefilled syringe utilizes the company's proprietary technology for the integration of automatic and ...
Tags: USPTO, ready-to-fill syringe, Unilife, prefilled syringe
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
Specialty pharmaceutical company Cynapsus Therapeutics has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application No. 13/445,656 that covers APL-130277. Fast-acting APL-130277 is a thin ...
The US Patent and Trademark Office (USPTO) has granted a patent No. 8,329,220 to Aegis Therapeutics' absorption-enhancing self-assembling aqueous hydrogels, designed for delivering peptide and small molecules. The Aegis Hydrogels, which ...
Tags: USPTO, Aegis Therapeutics, aqueous hydrogels
The US Patent and Trademark Office (USPTO) has granted a patent No. 8,332,072 to Titan Medical for the development of surgeon console that incorporates force feedback. The Amadeus surgical system is designed to deliver multiple benefits ...
Tags: USPTO, patent, surgeon console, surgeon
The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy. The patent, which will be issued on 25 December 2012, covers claims related to ...
Tags: Sequenom, US patent, fetal aneuploidy, USPTO
The US Patent and Trademark Office (USPTO) has granted a patent to Pearl Therapeutics' co-suspension formulation technology for inhaled combinations. The Patent No. 8,324,266 covers methods for treating pulmonary disease using Pearl's ...
The US Patent and Trademark Office (USPTO) has granted new patent No. #8241330 to Lanx's Aspen MIS Fusion system, designed to support posterolateral fusions and interbody fusions. The Aspen system features proprietary spiked fixation ...
Tags: USPTO, MIS Fusion system, posterolateral fusions, interbody fusions
Bioplastics manufacturer Cereplast has secured patent protection for high heat resistant polymer compositions having polylactic acid (PLA), from the United States Patent and Trademark Office (USPTO). The patent 8,222,320 issued by USPTO ...
Tags: Resistant Polymer, bioplastic resin, patent protection
The US Patent and Trademark Office (USPTO) has granted a new Patent No. 8,298,554 to Amarin's pharmaceutical composition of ultra pure omega-3 fatty acid product. The patent covers the claims related to application No.12/769,885 for the ...
Tags: ultra pure omega-3 fatty acid product, vascepa capsules, icosapent ethyl
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detection for use in determining cancerous ...
Tags: USPTO, Lifeline Biotechnologies'device, analyzing, surface temperature
The US Patent and Trademark Office (USPTO) has granted a patent for the use of Aeterna Zentaris' oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency (AGHD). AEZS-130, which has been granted ...
Tags: AEZS-130, growth hormone deficiency, AGHD
MicuRx Pharmaceuticals has received a US patent from the USPTO covering the composition of its clinical candidate, MRX-I. The antibacterial oxazolidinone targets infections due to multi-drug resistant Gram-positive pathogens. MicuRx ...
Tags: MicuRx Pharmaceuticals, MRX-I